An accumulating body of data indicates that the apoB/apoA1 ratio is a powerful marker of risk for future cardiovascular disease[12], but the different relationships between the plasma apoB, apoA1, apoB/apoA1 ratio and the prevalence of CHD in normal- or over-weight and obese groups have not been consistently shown. This evidence concerns the gene APOB and coronary artery disorder.